Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content. This shows the page is currently blocked from access.SummaryDifference20%

- Check19 days agoChange DetectedThe page's revision tag has been updated to v3.7.0, signaling a newer build of the page. This metadata change does not modify the study details or user-facing content.SummaryDifference0.0%

- Check33 days agoChange DetectedA new site revision tag (Revision: v3.6.6) replaces the previous Revision: v3.6.5, reflecting a minor update to the page infrastructure.SummaryDifference0.0%

- Check40 days agoChange DetectedA new NIH funding identifier was added to the study’s identifiers: 2014 ( U.S. NIH Grant/Contract ). This addition links the record to NIH-supported funding for the trial, clarifying its funding source.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This appears to be a backend software update with no changes to study content or page layout.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page footer now displays Revision: v3.6.4, replacing v3.6.3. This indicates a small site version update rather than a modification to the study data or text.SummaryDifference0.0%

Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.